Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer

Wüstmann, N; Seitzer, K; Humberg, V; Vieler, J; Grundmann, N; Steinestel, J; Tiedje, D; Duensing, S; Krabbe, LM; Bögemann, M; Schrader, AJ; Bernemann, C; Schlack, K

Bernemann, C (通讯作者),Univ Hosp Muenster, Dept Urol, Albert Schweitzer Campus 1 A1, D-48149 Munster, Germany.

BIOMARKER RESEARCH, 2023; 11 (1):

Abstract

BackgroundAndrogen receptor (AR) splice variants (AR-Vs) have been discussed as a biomarker in prostate cancer (PC). However, some reports question th......

Full Text Link